Tabunyag, Letecia C.

HRN: 13-30-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
CEFTRIAXONE 1G (VIAL)
07/03/2023
07/09/2023
IV
2G
Od
UTI
Waiting Final Action 
07/01/2024
CEFTRIAXONE 1G (VIAL)
07/01/2024
07/08/2024
IV
2 Grams
OD
PUD
Waiting Final Action 
07/05/2024
CEFUROXIME 500MG (TAB)
07/05/2024
07/12/2024
ORAL
500mg
BID
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: